Context Therapeutics (CNTX) Prepaid Assets (2020 - 2026)
Context Therapeutics' (CNTX) quarterly Prepaid Assets came in at $4.0 million in Q1 2026, up 18.04% year-on-year from $3.4 million in Q1 2025, and up 69.1% quarter-over-quarter from $2.4 million in Q4 2025.
Context Therapeutics (CNTX) Prepaid Assets (2020 - 2026) Analysis & Trends
Context Therapeutics has disclosed Prepaid Assets across 7 years of filings, most recently posting $4.0 million for Q1 2026.
- Prepaid Assets for Q1 2026 came in at $4.0 million, up 18.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.0 million (up 18.04% YoY), and the FY2025 annual result was $2.4 million, down 31.96% from the prior year.
- Prepaid Assets came in at $4.0 million for Q1 2026 at Context Therapeutics, up from $2.4 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $4.0 million in Q1 2026 to a low of $949489.0 in Q1 2024.
- The 5-year median for Prepaid Assets is $2.1 million (2025), against an average of $2.2 million.
- Across the five-year window, Prepaid Assets jumped 13568.19% in 2022 and slumped 55.14% in 2024, its largest moves.
- Context Therapeutics' Prepaid Assets stood at $2.4 million in 2022, then tumbled by 32.21% to $1.6 million in 2023, then soared by 116.99% to $3.5 million in 2024, then tumbled by 31.96% to $2.4 million in 2025, then surged by 69.1% to $4.0 million in 2026.
- The last three Prepaid Assets figures came in at $4.0 million (Q1 2026), $2.4 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Context Therapeutics | 166.57 Mn | 166.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.99 Mn |
| Dec 31, 2025 | 2.36 Mn |
| Sep 30, 2025 | 2.12 Mn |
| Jun 30, 2025 | 3.43 Mn |
| Mar 31, 2025 | 3.38 Mn |
| Dec 31, 2024 | 3.47 Mn |
| Sep 30, 2024 | 1.27 Mn |
| Jun 30, 2024 | 1.16 Mn |
| Mar 31, 2024 | 949,489.00 |
| Dec 31, 2023 | 1.60 Mn |
| Sep 30, 2023 | 1.29 Mn |
| Jun 30, 2023 | 2.57 Mn |
| Mar 31, 2023 | 2.12 Mn |
| Dec 31, 2022 | 2.36 Mn |
| Sep 30, 2022 | 2.51 Mn |
| Jun 30, 2022 | 1.58 Mn |
| Mar 31, 2022 | 1.13 Mn |
| Dec 31, 2021 | 1.62 Mn |
| Sep 30, 2021 | 18,379.00 |
| Dec 31, 2020 | 8,672.00 |